# Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

> **NCT00119431** · PHASE2 · COMPLETED · sponsor: **Prothya Biosolutions** · enrollment: 12 (estimated)

## Conditions studied

- Hereditary Angioedema Type I
- Angioneurotic Edema

## Interventions

- **DRUG:** C1 inhibitor concentrate

## Key facts

- **NCT ID:** NCT00119431
- **Lead sponsor:** Prothya Biosolutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119431, "Kinetics, Efficacy and Safety of C1-Esteraseremmer-N". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00119431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*